Finance

Lists
1VTRS:BIT
Viatris Inc
€14.49
-1.00%
(-0.15) 1D
Sep 4, 5:26:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1VTRS...
Open
€14.49
High
€14.49
Low
€14.49
Mkt. cap
19.39B
Avg. vol.
168.00
Volume
281.00
52-wk high
€15.73
52-wk low
€8.09
No. of employees
30K
Open
€14.49
High
€14.49
Low
€14.49
Mkt. cap
19.39B
Avg. vol.
168.00
Volume
281.00
52-wk high
€15.73
52-wk low
€8.09
No. of employees
30K
Profile
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue. In 2026, Viatris ranked 100 on Time Magazine's World's Most Impactful Companies. Wikipedia
About Viatris Inc
CEOScott A. Smith
Employees30K
FoundedNov 16, 2020
HeadquartersCanonsburg, Pennsylvania, United States
SectorPharmaceutical industry
Websiteviatris.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.76B
3.70B
3.52B
3.76B
Cost of goods sold
2.26B
2.21B
2.14B
2.19B
Cost of revenue
2.26B
2.21B
2.14B
2.19B
Research and development expenses
244.80M
271.20M
245.80M
245.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
848.50M
933.40M
893.40M
855.00M
Operating expense
1.09B
1.20B
1.14B
1.10B
Total operating expenses
3.36B
3.42B
3.28B
3.29B
Operating income
404.60M
288.20M
238.60M
471.50M
Other non operating income
-135.90M
44.90M
-1.80M
14.40M
EBT including unusual items
-7.90M
-343.00M
-247.30M
-64.00M
EBT excluding unusual items
318.70M
188.00M
146.20M
365.40M
Income tax expense
120.30M
-2.90M
-423.70M
54.80M
Effective tax rate
-1,522.78%
0.85%
171.33%
-85.62%
Other operating expenses
-
-
-
-
Net income
-128.20M
-340.10M
176.40M
-118.80M
Net profit margin
-3.41%
-9.18%
5.02%
-3.16%
Earnings per share
0.67
0.57
0.59
0.69
Interest and investment income
-
-
-
-
Interest expense
-119.60M
-119.60M
-120.10M
-120.70M
Net interest expenses
-119.60M
-119.60M
-120.10M
-120.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.09B
981.10M
914.70M
1.14B
Gain or loss from assets sale
-1.60M
21.90M
13.90M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps